iPSC-derived Myoblast Kit

iPSC-Derived Myoblasts provide a renewable, standardized, and physiologically relevant model for skeletal muscle research. Generated from human induced pluripotent stem cells, these myogenic precursors closely resemble primary myoblasts while offering unlimited scalability. Each lot is rigorously characterized by strong expression of CD56, MyoD, and myogenin, confirming their myogenic identity and quality. Upon differentiation, the cells efficiently form multinucleated myotubes, validated by MHC staining and characteristic morphology. We are establishing a panel of iPSC derived myoblasts (iMyoblasts) from patients with muscle degenerative diseases, enabling disease modeling, mechanistic studies, and therapeutic development in a patient-specific context.iPSC-derived myoblasts (iMyoblasts) are ideally suited for studies of muscle development, regeneration, drug screening, gene therapy testing, and regenerative medicine applications, offering a reliable platform for advancing muscle biology and translational research.

Please contact us for more information.